nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—ABCG2—Tamoxifen—pancreatic cancer	0.0566	0.0888	CbGbCtD
Pantoprazole—SLCO1B1—Irinotecan—pancreatic cancer	0.0547	0.0859	CbGbCtD
Pantoprazole—ABCG2—Erlotinib—pancreatic cancer	0.0481	0.0755	CbGbCtD
Pantoprazole—ABCG2—Irinotecan—pancreatic cancer	0.0434	0.0682	CbGbCtD
Pantoprazole—ABCG2—Fluorouracil—pancreatic cancer	0.0417	0.0655	CbGbCtD
Pantoprazole—ATP4A—gastric juice—pancreatic cancer	0.0383	0.749	CbGeAlD
Pantoprazole—ABCG2—Docetaxel—pancreatic cancer	0.0318	0.05	CbGbCtD
Pantoprazole—ABCG2—Sunitinib—pancreatic cancer	0.0317	0.0498	CbGbCtD
Pantoprazole—CYP1A2—Dacarbazine—pancreatic cancer	0.0293	0.0461	CbGbCtD
Pantoprazole—CYP2C19—Tamoxifen—pancreatic cancer	0.0253	0.0397	CbGbCtD
Pantoprazole—ABCG2—Doxorubicin—pancreatic cancer	0.0237	0.0373	CbGbCtD
Pantoprazole—CYP1A2—Tamoxifen—pancreatic cancer	0.0233	0.0366	CbGbCtD
Pantoprazole—CYP2C9—Tamoxifen—pancreatic cancer	0.021	0.033	CbGbCtD
Pantoprazole—ABCB1—Tamoxifen—pancreatic cancer	0.0204	0.032	CbGbCtD
Pantoprazole—CYP1A2—Erlotinib—pancreatic cancer	0.0198	0.0312	CbGbCtD
Pantoprazole—ABCB1—Gemcitabine—pancreatic cancer	0.0176	0.0276	CbGbCtD
Pantoprazole—ABCB1—Erlotinib—pancreatic cancer	0.0173	0.0272	CbGbCtD
Pantoprazole—CYP1A2—Fluorouracil—pancreatic cancer	0.0172	0.027	CbGbCtD
Pantoprazole—ABCB1—Irinotecan—pancreatic cancer	0.0157	0.0246	CbGbCtD
Pantoprazole—CYP2C9—Fluorouracil—pancreatic cancer	0.0155	0.0243	CbGbCtD
Pantoprazole—CYP3A4—Tamoxifen—pancreatic cancer	0.0122	0.0192	CbGbCtD
Pantoprazole—ABCB1—Docetaxel—pancreatic cancer	0.0115	0.018	CbGbCtD
Pantoprazole—ABCB1—Sunitinib—pancreatic cancer	0.0114	0.0179	CbGbCtD
Pantoprazole—CYP3A4—Erlotinib—pancreatic cancer	0.0104	0.0163	CbGbCtD
Pantoprazole—CYP3A4—Irinotecan—pancreatic cancer	0.00938	0.0147	CbGbCtD
Pantoprazole—ABCB1—Doxorubicin—pancreatic cancer	0.00856	0.0134	CbGbCtD
Pantoprazole—CYP3A4—Docetaxel—pancreatic cancer	0.00688	0.0108	CbGbCtD
Pantoprazole—CYP3A4—Sunitinib—pancreatic cancer	0.00685	0.0108	CbGbCtD
Pantoprazole—ATP4B—digestive system—pancreatic cancer	0.00537	0.105	CbGeAlD
Pantoprazole—CYP3A4—Doxorubicin—pancreatic cancer	0.00513	0.00805	CbGbCtD
Pantoprazole—ATP4A—digestive system—pancreatic cancer	0.00234	0.0457	CbGeAlD
Pantoprazole—SLCO1B1—digestive system—pancreatic cancer	0.00125	0.0245	CbGeAlD
Pantoprazole—CYP2C19—digestive system—pancreatic cancer	0.000817	0.0159	CbGeAlD
Pantoprazole—CYP1A2—digestive system—pancreatic cancer	0.000667	0.013	CbGeAlD
Pantoprazole—CYP2C9—digestive system—pancreatic cancer	0.000633	0.0124	CbGeAlD
Pantoprazole—ABCB1—islet of Langerhans—pancreatic cancer	0.000569	0.0111	CbGeAlD
Pantoprazole—CYP3A4—digestive system—pancreatic cancer	0.000483	0.00943	CbGeAlD
Pantoprazole—ABCB1—pancreas—pancreatic cancer	0.0004	0.00782	CbGeAlD
Pantoprazole—ABCB1—digestive system—pancreatic cancer	0.000342	0.00667	CbGeAlD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—pancreatic cancer	0.000203	0.00306	CbGpPWpGaD
Pantoprazole—ABCG2—HIF-1-alpha transcription factor network—SMAD4—pancreatic cancer	0.000201	0.00303	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000195	0.00295	CbGpPWpGaD
Pantoprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—pancreatic cancer	0.000184	0.00277	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000181	0.00273	CbGpPWpGaD
Pantoprazole—ABCG2—HIF-1-alpha transcription factor network—TERT—pancreatic cancer	0.000172	0.00259	CbGpPWpGaD
Pantoprazole—CYP2C19—Melatonin metabolism and effects—APOE—pancreatic cancer	0.000171	0.00259	CbGpPWpGaD
Pantoprazole—ABCG2—HIF-1-alpha transcription factor network—HIF1A—pancreatic cancer	0.000164	0.00248	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000159	0.0024	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.000159	0.00239	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000147	0.00222	CbGpPWpGaD
Pantoprazole—ABCG2—HIF-2-alpha transcription factor network—VEGFA—pancreatic cancer	0.000147	0.00222	CbGpPWpGaD
Pantoprazole—CYP1A2—Estrogen Receptor Pathway—STAT3—pancreatic cancer	0.000136	0.00205	CbGpPWpGaD
Pantoprazole—CYP1A2—Melatonin metabolism and effects—APOE—pancreatic cancer	0.000134	0.00202	CbGpPWpGaD
Pantoprazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000128	0.00194	CbGpPWpGaD
Pantoprazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.00012	0.00181	CbGpPWpGaD
Pantoprazole—SLCO1B1—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000118	0.00179	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000115	0.00174	CbGpPWpGaD
Pantoprazole—ABCG2—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000114	0.00172	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—pancreatic cancer	0.000113	0.0017	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—AGTR1—pancreatic cancer	0.000109	0.00164	CbGpPWpGaD
Pantoprazole—ABCB1—HIF-1-alpha transcription factor network—SMAD4—pancreatic cancer	0.000109	0.00164	CbGpPWpGaD
Pantoprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000102	0.00155	CbGpPWpGaD
Pantoprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	0.000101	0.00152	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	9.78e-05	0.00148	CbGpPWpGaD
Pantoprazole—ABCB1—HIF-1-alpha transcription factor network—TERT—pancreatic cancer	9.28e-05	0.0014	CbGpPWpGaD
Pantoprazole—ABCB1—HIF-1-alpha transcription factor network—HIF1A—pancreatic cancer	8.88e-05	0.00134	CbGpPWpGaD
Pantoprazole—ABCG2—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	8.65e-05	0.00131	CbGpPWpGaD
Pantoprazole—Photosensitivity reaction—Doxorubicin—pancreatic cancer	8.58e-05	0.000349	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Epirubicin—pancreatic cancer	8.57e-05	0.000349	CcSEcCtD
Pantoprazole—Anaphylactic shock—Docetaxel—pancreatic cancer	8.57e-05	0.000349	CcSEcCtD
Pantoprazole—Oedema—Docetaxel—pancreatic cancer	8.57e-05	0.000349	CcSEcCtD
Pantoprazole—Weight increased—Doxorubicin—pancreatic cancer	8.56e-05	0.000348	CcSEcCtD
Pantoprazole—Epistaxis—Epirubicin—pancreatic cancer	8.54e-05	0.000348	CcSEcCtD
Pantoprazole—Pruritus—Gemcitabine—pancreatic cancer	8.54e-05	0.000347	CcSEcCtD
Pantoprazole—Infection—Docetaxel—pancreatic cancer	8.51e-05	0.000346	CcSEcCtD
Pantoprazole—Weight decreased—Doxorubicin—pancreatic cancer	8.5e-05	0.000346	CcSEcCtD
Pantoprazole—Sinusitis—Epirubicin—pancreatic cancer	8.5e-05	0.000346	CcSEcCtD
Pantoprazole—Hyperglycaemia—Doxorubicin—pancreatic cancer	8.48e-05	0.000345	CcSEcCtD
Pantoprazole—Diarrhoea—Irinotecan—pancreatic cancer	8.48e-05	0.000345	CcSEcCtD
Pantoprazole—Agranulocytosis—Epirubicin—pancreatic cancer	8.45e-05	0.000344	CcSEcCtD
Pantoprazole—Pneumonia—Doxorubicin—pancreatic cancer	8.43e-05	0.000343	CcSEcCtD
Pantoprazole—Shock—Docetaxel—pancreatic cancer	8.43e-05	0.000343	CcSEcCtD
Pantoprazole—Nervous system disorder—Docetaxel—pancreatic cancer	8.4e-05	0.000342	CcSEcCtD
Pantoprazole—Pruritus—Fluorouracil—pancreatic cancer	8.4e-05	0.000342	CcSEcCtD
Pantoprazole—Thrombocytopenia—Docetaxel—pancreatic cancer	8.39e-05	0.000341	CcSEcCtD
Pantoprazole—Infestation—Doxorubicin—pancreatic cancer	8.38e-05	0.000341	CcSEcCtD
Pantoprazole—Infestation NOS—Doxorubicin—pancreatic cancer	8.38e-05	0.000341	CcSEcCtD
Pantoprazole—Tachycardia—Docetaxel—pancreatic cancer	8.36e-05	0.00034	CcSEcCtD
Pantoprazole—Skin disorder—Docetaxel—pancreatic cancer	8.32e-05	0.000339	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	8.31e-05	0.000338	CcSEcCtD
Pantoprazole—Diarrhoea—Gemcitabine—pancreatic cancer	8.26e-05	0.000336	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Doxorubicin—pancreatic cancer	8.22e-05	0.000334	CcSEcCtD
Pantoprazole—Dizziness—Irinotecan—pancreatic cancer	8.19e-05	0.000333	CcSEcCtD
Pantoprazole—Haemoglobin—Epirubicin—pancreatic cancer	8.17e-05	0.000333	CcSEcCtD
Pantoprazole—Jaundice—Doxorubicin—pancreatic cancer	8.17e-05	0.000332	CcSEcCtD
Pantoprazole—Stomatitis—Doxorubicin—pancreatic cancer	8.17e-05	0.000332	CcSEcCtD
Pantoprazole—Anorexia—Docetaxel—pancreatic cancer	8.16e-05	0.000332	CcSEcCtD
Pantoprazole—Rhinitis—Epirubicin—pancreatic cancer	8.15e-05	0.000332	CcSEcCtD
Pantoprazole—Conjunctivitis—Doxorubicin—pancreatic cancer	8.15e-05	0.000332	CcSEcCtD
Pantoprazole—Urinary tract infection—Doxorubicin—pancreatic cancer	8.15e-05	0.000332	CcSEcCtD
Pantoprazole—Haemorrhage—Epirubicin—pancreatic cancer	8.13e-05	0.000331	CcSEcCtD
Pantoprazole—Hepatitis—Epirubicin—pancreatic cancer	8.13e-05	0.000331	CcSEcCtD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	8.12e-05	0.00123	CbGpPWpGaD
Pantoprazole—Diarrhoea—Fluorouracil—pancreatic cancer	8.12e-05	0.00033	CcSEcCtD
Pantoprazole—Hypoaesthesia—Epirubicin—pancreatic cancer	8.09e-05	0.000329	CcSEcCtD
Pantoprazole—Pharyngitis—Epirubicin—pancreatic cancer	8.07e-05	0.000328	CcSEcCtD
Pantoprazole—Sweating—Doxorubicin—pancreatic cancer	8.04e-05	0.000327	CcSEcCtD
Pantoprazole—Urinary tract disorder—Epirubicin—pancreatic cancer	8.03e-05	0.000327	CcSEcCtD
Pantoprazole—Oedema peripheral—Epirubicin—pancreatic cancer	8.01e-05	0.000326	CcSEcCtD
Pantoprazole—Hypotension—Docetaxel—pancreatic cancer	8e-05	0.000326	CcSEcCtD
Pantoprazole—Haematuria—Doxorubicin—pancreatic cancer	7.99e-05	0.000325	CcSEcCtD
Pantoprazole—Connective tissue disorder—Epirubicin—pancreatic cancer	7.99e-05	0.000325	CcSEcCtD
Pantoprazole—Urethral disorder—Epirubicin—pancreatic cancer	7.97e-05	0.000324	CcSEcCtD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	7.97e-05	0.0012	CbGpPWpGaD
Pantoprazole—Hepatobiliary disease—Doxorubicin—pancreatic cancer	7.93e-05	0.000323	CcSEcCtD
Pantoprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	7.91e-05	0.00119	CbGpPWpGaD
Pantoprazole—Epistaxis—Doxorubicin—pancreatic cancer	7.91e-05	0.000322	CcSEcCtD
Pantoprazole—Vomiting—Irinotecan—pancreatic cancer	7.88e-05	0.000321	CcSEcCtD
Pantoprazole—Sinusitis—Doxorubicin—pancreatic cancer	7.86e-05	0.00032	CcSEcCtD
Pantoprazole—Dizziness—Fluorouracil—pancreatic cancer	7.85e-05	0.000319	CcSEcCtD
Pantoprazole—Visual impairment—Epirubicin—pancreatic cancer	7.84e-05	0.000319	CcSEcCtD
Pantoprazole—Agranulocytosis—Doxorubicin—pancreatic cancer	7.82e-05	0.000318	CcSEcCtD
Pantoprazole—Rash—Irinotecan—pancreatic cancer	7.81e-05	0.000318	CcSEcCtD
Pantoprazole—Dermatitis—Irinotecan—pancreatic cancer	7.81e-05	0.000318	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	7.8e-05	0.000318	CcSEcCtD
Pantoprazole—Headache—Irinotecan—pancreatic cancer	7.76e-05	0.000316	CcSEcCtD
Pantoprazole—Insomnia—Docetaxel—pancreatic cancer	7.75e-05	0.000315	CcSEcCtD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—RB1—pancreatic cancer	7.7e-05	0.00116	CbGpPWpGaD
Pantoprazole—Paraesthesia—Docetaxel—pancreatic cancer	7.69e-05	0.000313	CcSEcCtD
Pantoprazole—Erythema multiforme—Epirubicin—pancreatic cancer	7.69e-05	0.000313	CcSEcCtD
Pantoprazole—Vomiting—Gemcitabine—pancreatic cancer	7.67e-05	0.000312	CcSEcCtD
Pantoprazole—Dyspnoea—Docetaxel—pancreatic cancer	7.64e-05	0.000311	CcSEcCtD
Pantoprazole—Somnolence—Docetaxel—pancreatic cancer	7.61e-05	0.00031	CcSEcCtD
Pantoprazole—Rash—Gemcitabine—pancreatic cancer	7.61e-05	0.00031	CcSEcCtD
Pantoprazole—Dermatitis—Gemcitabine—pancreatic cancer	7.6e-05	0.000309	CcSEcCtD
Pantoprazole—Eye disorder—Epirubicin—pancreatic cancer	7.6e-05	0.000309	CcSEcCtD
Pantoprazole—CYP2C19—Arachidonic acid metabolism—PTGS2—pancreatic cancer	7.6e-05	0.00115	CbGpPWpGaD
Pantoprazole—Tinnitus—Epirubicin—pancreatic cancer	7.58e-05	0.000309	CcSEcCtD
Pantoprazole—Haemoglobin—Doxorubicin—pancreatic cancer	7.56e-05	0.000308	CcSEcCtD
Pantoprazole—Headache—Gemcitabine—pancreatic cancer	7.56e-05	0.000308	CcSEcCtD
Pantoprazole—Flushing—Epirubicin—pancreatic cancer	7.55e-05	0.000307	CcSEcCtD
Pantoprazole—Vomiting—Fluorouracil—pancreatic cancer	7.55e-05	0.000307	CcSEcCtD
Pantoprazole—Rhinitis—Doxorubicin—pancreatic cancer	7.54e-05	0.000307	CcSEcCtD
Pantoprazole—Dyspepsia—Docetaxel—pancreatic cancer	7.54e-05	0.000307	CcSEcCtD
Pantoprazole—Haemorrhage—Doxorubicin—pancreatic cancer	7.52e-05	0.000306	CcSEcCtD
Pantoprazole—Hepatitis—Doxorubicin—pancreatic cancer	7.52e-05	0.000306	CcSEcCtD
Pantoprazole—Hypoaesthesia—Doxorubicin—pancreatic cancer	7.49e-05	0.000305	CcSEcCtD
Pantoprazole—Rash—Fluorouracil—pancreatic cancer	7.48e-05	0.000304	CcSEcCtD
Pantoprazole—Dermatitis—Fluorouracil—pancreatic cancer	7.48e-05	0.000304	CcSEcCtD
Pantoprazole—Pharyngitis—Doxorubicin—pancreatic cancer	7.47e-05	0.000304	CcSEcCtD
Pantoprazole—Decreased appetite—Docetaxel—pancreatic cancer	7.45e-05	0.000303	CcSEcCtD
Pantoprazole—Headache—Fluorouracil—pancreatic cancer	7.43e-05	0.000303	CcSEcCtD
Pantoprazole—Urinary tract disorder—Doxorubicin—pancreatic cancer	7.43e-05	0.000302	CcSEcCtD
Pantoprazole—Oedema peripheral—Doxorubicin—pancreatic cancer	7.41e-05	0.000302	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Docetaxel—pancreatic cancer	7.39e-05	0.000301	CcSEcCtD
Pantoprazole—Connective tissue disorder—Doxorubicin—pancreatic cancer	7.39e-05	0.000301	CcSEcCtD
Pantoprazole—Fatigue—Docetaxel—pancreatic cancer	7.38e-05	0.000301	CcSEcCtD
Pantoprazole—Urethral disorder—Doxorubicin—pancreatic cancer	7.38e-05	0.0003	CcSEcCtD
Pantoprazole—Nausea—Irinotecan—pancreatic cancer	7.36e-05	0.000299	CcSEcCtD
Pantoprazole—Immune system disorder—Epirubicin—pancreatic cancer	7.35e-05	0.000299	CcSEcCtD
Pantoprazole—Constipation—Docetaxel—pancreatic cancer	7.32e-05	0.000298	CcSEcCtD
Pantoprazole—Pain—Docetaxel—pancreatic cancer	7.32e-05	0.000298	CcSEcCtD
Pantoprazole—Chills—Epirubicin—pancreatic cancer	7.3e-05	0.000297	CcSEcCtD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	7.29e-05	0.0011	CbGpPWpGaD
Pantoprazole—Arrhythmia—Epirubicin—pancreatic cancer	7.26e-05	0.000296	CcSEcCtD
Pantoprazole—Visual impairment—Doxorubicin—pancreatic cancer	7.25e-05	0.000295	CcSEcCtD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	7.2e-05	0.00109	CbGpPWpGaD
Pantoprazole—Alopecia—Epirubicin—pancreatic cancer	7.19e-05	0.000292	CcSEcCtD
Pantoprazole—Nausea—Gemcitabine—pancreatic cancer	7.17e-05	0.000292	CcSEcCtD
Pantoprazole—Mental disorder—Epirubicin—pancreatic cancer	7.12e-05	0.00029	CcSEcCtD
Pantoprazole—Erythema multiforme—Doxorubicin—pancreatic cancer	7.11e-05	0.000289	CcSEcCtD
Pantoprazole—Malnutrition—Epirubicin—pancreatic cancer	7.08e-05	0.000288	CcSEcCtD
Pantoprazole—Feeling abnormal—Docetaxel—pancreatic cancer	7.06e-05	0.000287	CcSEcCtD
Pantoprazole—Nausea—Fluorouracil—pancreatic cancer	7.05e-05	0.000287	CcSEcCtD
Pantoprazole—Eye disorder—Doxorubicin—pancreatic cancer	7.03e-05	0.000286	CcSEcCtD
Pantoprazole—Tinnitus—Doxorubicin—pancreatic cancer	7.02e-05	0.000285	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Docetaxel—pancreatic cancer	7e-05	0.000285	CcSEcCtD
Pantoprazole—Flushing—Doxorubicin—pancreatic cancer	6.98e-05	0.000284	CcSEcCtD
Pantoprazole—Flatulence—Epirubicin—pancreatic cancer	6.98e-05	0.000284	CcSEcCtD
Pantoprazole—Tension—Epirubicin—pancreatic cancer	6.95e-05	0.000283	CcSEcCtD
Pantoprazole—Dysgeusia—Epirubicin—pancreatic cancer	6.93e-05	0.000282	CcSEcCtD
Pantoprazole—CYP2C9—Arachidonic acid metabolism—PTGS2—pancreatic cancer	6.93e-05	0.00105	CbGpPWpGaD
Pantoprazole—Nervousness—Epirubicin—pancreatic cancer	6.88e-05	0.00028	CcSEcCtD
Pantoprazole—Back pain—Epirubicin—pancreatic cancer	6.85e-05	0.000279	CcSEcCtD
Pantoprazole—Muscle spasms—Epirubicin—pancreatic cancer	6.81e-05	0.000277	CcSEcCtD
Pantoprazole—Immune system disorder—Doxorubicin—pancreatic cancer	6.8e-05	0.000277	CcSEcCtD
Pantoprazole—Body temperature increased—Docetaxel—pancreatic cancer	6.77e-05	0.000276	CcSEcCtD
Pantoprazole—Abdominal pain—Docetaxel—pancreatic cancer	6.77e-05	0.000276	CcSEcCtD
Pantoprazole—Chills—Doxorubicin—pancreatic cancer	6.75e-05	0.000275	CcSEcCtD
Pantoprazole—Arrhythmia—Doxorubicin—pancreatic cancer	6.72e-05	0.000274	CcSEcCtD
Pantoprazole—Vision blurred—Epirubicin—pancreatic cancer	6.67e-05	0.000271	CcSEcCtD
Pantoprazole—Alopecia—Doxorubicin—pancreatic cancer	6.65e-05	0.000271	CcSEcCtD
Pantoprazole—Mental disorder—Doxorubicin—pancreatic cancer	6.59e-05	0.000268	CcSEcCtD
Pantoprazole—Ill-defined disorder—Epirubicin—pancreatic cancer	6.57e-05	0.000267	CcSEcCtD
Pantoprazole—Malnutrition—Doxorubicin—pancreatic cancer	6.55e-05	0.000267	CcSEcCtD
Pantoprazole—Anaemia—Epirubicin—pancreatic cancer	6.54e-05	0.000266	CcSEcCtD
Pantoprazole—Agitation—Epirubicin—pancreatic cancer	6.51e-05	0.000265	CcSEcCtD
Pantoprazole—Flatulence—Doxorubicin—pancreatic cancer	6.45e-05	0.000263	CcSEcCtD
Pantoprazole—Tension—Doxorubicin—pancreatic cancer	6.43e-05	0.000262	CcSEcCtD
Pantoprazole—Dysgeusia—Doxorubicin—pancreatic cancer	6.41e-05	0.000261	CcSEcCtD
Pantoprazole—Malaise—Epirubicin—pancreatic cancer	6.38e-05	0.00026	CcSEcCtD
Pantoprazole—Nervousness—Doxorubicin—pancreatic cancer	6.36e-05	0.000259	CcSEcCtD
Pantoprazole—Vertigo—Epirubicin—pancreatic cancer	6.36e-05	0.000259	CcSEcCtD
Pantoprazole—Syncope—Epirubicin—pancreatic cancer	6.35e-05	0.000258	CcSEcCtD
Pantoprazole—Leukopenia—Epirubicin—pancreatic cancer	6.34e-05	0.000258	CcSEcCtD
Pantoprazole—Back pain—Doxorubicin—pancreatic cancer	6.34e-05	0.000258	CcSEcCtD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—pancreatic cancer	6.33e-05	0.000955	CbGpPWpGaD
Pantoprazole—Hypersensitivity—Docetaxel—pancreatic cancer	6.31e-05	0.000257	CcSEcCtD
Pantoprazole—Muscle spasms—Doxorubicin—pancreatic cancer	6.3e-05	0.000256	CcSEcCtD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	6.29e-05	0.000949	CbGpPWpGaD
Pantoprazole—Palpitations—Epirubicin—pancreatic cancer	6.26e-05	0.000255	CcSEcCtD
Pantoprazole—Loss of consciousness—Epirubicin—pancreatic cancer	6.22e-05	0.000253	CcSEcCtD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	6.18e-05	0.000933	CbGpPWpGaD
Pantoprazole—Cough—Epirubicin—pancreatic cancer	6.18e-05	0.000251	CcSEcCtD
Pantoprazole—Vision blurred—Doxorubicin—pancreatic cancer	6.17e-05	0.000251	CcSEcCtD
Pantoprazole—Asthenia—Docetaxel—pancreatic cancer	6.15e-05	0.00025	CcSEcCtD
Pantoprazole—Convulsion—Epirubicin—pancreatic cancer	6.13e-05	0.00025	CcSEcCtD
Pantoprazole—Hypertension—Epirubicin—pancreatic cancer	6.11e-05	0.000249	CcSEcCtD
Pantoprazole—Ill-defined disorder—Doxorubicin—pancreatic cancer	6.08e-05	0.000247	CcSEcCtD
Pantoprazole—Pruritus—Docetaxel—pancreatic cancer	6.06e-05	0.000247	CcSEcCtD
Pantoprazole—Anaemia—Doxorubicin—pancreatic cancer	6.05e-05	0.000246	CcSEcCtD
Pantoprazole—Arthralgia—Epirubicin—pancreatic cancer	6.03e-05	0.000245	CcSEcCtD
Pantoprazole—Chest pain—Epirubicin—pancreatic cancer	6.03e-05	0.000245	CcSEcCtD
Pantoprazole—Myalgia—Epirubicin—pancreatic cancer	6.03e-05	0.000245	CcSEcCtD
Pantoprazole—Agitation—Doxorubicin—pancreatic cancer	6.02e-05	0.000245	CcSEcCtD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.02e-05	0.000908	CbGpPWpGaD
Pantoprazole—Anxiety—Epirubicin—pancreatic cancer	6.01e-05	0.000244	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	5.99e-05	0.000244	CcSEcCtD
Pantoprazole—Discomfort—Epirubicin—pancreatic cancer	5.95e-05	0.000242	CcSEcCtD
Pantoprazole—CYP1A2—Arachidonic acid metabolism—PTGS2—pancreatic cancer	5.92e-05	0.000893	CbGpPWpGaD
Pantoprazole—Malaise—Doxorubicin—pancreatic cancer	5.91e-05	0.00024	CcSEcCtD
Pantoprazole—Dry mouth—Epirubicin—pancreatic cancer	5.89e-05	0.00024	CcSEcCtD
Pantoprazole—Vertigo—Doxorubicin—pancreatic cancer	5.88e-05	0.000239	CcSEcCtD
Pantoprazole—Syncope—Doxorubicin—pancreatic cancer	5.87e-05	0.000239	CcSEcCtD
Pantoprazole—Leukopenia—Doxorubicin—pancreatic cancer	5.86e-05	0.000239	CcSEcCtD
Pantoprazole—Diarrhoea—Docetaxel—pancreatic cancer	5.86e-05	0.000238	CcSEcCtD
Pantoprazole—Confusional state—Epirubicin—pancreatic cancer	5.83e-05	0.000237	CcSEcCtD
Pantoprazole—Palpitations—Doxorubicin—pancreatic cancer	5.79e-05	0.000236	CcSEcCtD
Pantoprazole—Oedema—Epirubicin—pancreatic cancer	5.78e-05	0.000235	CcSEcCtD
Pantoprazole—Anaphylactic shock—Epirubicin—pancreatic cancer	5.78e-05	0.000235	CcSEcCtD
Pantoprazole—Loss of consciousness—Doxorubicin—pancreatic cancer	5.76e-05	0.000234	CcSEcCtD
Pantoprazole—Infection—Epirubicin—pancreatic cancer	5.74e-05	0.000234	CcSEcCtD
Pantoprazole—Cough—Doxorubicin—pancreatic cancer	5.72e-05	0.000233	CcSEcCtD
Pantoprazole—Shock—Epirubicin—pancreatic cancer	5.68e-05	0.000231	CcSEcCtD
Pantoprazole—Convulsion—Doxorubicin—pancreatic cancer	5.68e-05	0.000231	CcSEcCtD
Pantoprazole—Nervous system disorder—Epirubicin—pancreatic cancer	5.67e-05	0.000231	CcSEcCtD
Pantoprazole—Dizziness—Docetaxel—pancreatic cancer	5.66e-05	0.00023	CcSEcCtD
Pantoprazole—Thrombocytopenia—Epirubicin—pancreatic cancer	5.66e-05	0.00023	CcSEcCtD
Pantoprazole—Hypertension—Doxorubicin—pancreatic cancer	5.66e-05	0.00023	CcSEcCtD
Pantoprazole—Tachycardia—Epirubicin—pancreatic cancer	5.64e-05	0.000229	CcSEcCtD
Pantoprazole—Skin disorder—Epirubicin—pancreatic cancer	5.61e-05	0.000228	CcSEcCtD
Pantoprazole—Hyperhidrosis—Epirubicin—pancreatic cancer	5.59e-05	0.000227	CcSEcCtD
Pantoprazole—Myalgia—Doxorubicin—pancreatic cancer	5.58e-05	0.000227	CcSEcCtD
Pantoprazole—Arthralgia—Doxorubicin—pancreatic cancer	5.58e-05	0.000227	CcSEcCtD
Pantoprazole—Chest pain—Doxorubicin—pancreatic cancer	5.58e-05	0.000227	CcSEcCtD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	5.57e-05	0.00084	CbGpPWpGaD
Pantoprazole—Anxiety—Doxorubicin—pancreatic cancer	5.56e-05	0.000226	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	5.54e-05	0.000225	CcSEcCtD
Pantoprazole—ABCG2—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	5.52e-05	0.000833	CbGpPWpGaD
Pantoprazole—Discomfort—Doxorubicin—pancreatic cancer	5.51e-05	0.000224	CcSEcCtD
Pantoprazole—Anorexia—Epirubicin—pancreatic cancer	5.51e-05	0.000224	CcSEcCtD
Pantoprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	5.46e-05	0.000824	CbGpPWpGaD
Pantoprazole—Dry mouth—Doxorubicin—pancreatic cancer	5.45e-05	0.000222	CcSEcCtD
Pantoprazole—Vomiting—Docetaxel—pancreatic cancer	5.45e-05	0.000222	CcSEcCtD
Pantoprazole—Rash—Docetaxel—pancreatic cancer	5.4e-05	0.00022	CcSEcCtD
Pantoprazole—Hypotension—Epirubicin—pancreatic cancer	5.4e-05	0.00022	CcSEcCtD
Pantoprazole—Dermatitis—Docetaxel—pancreatic cancer	5.4e-05	0.00022	CcSEcCtD
Pantoprazole—Confusional state—Doxorubicin—pancreatic cancer	5.39e-05	0.000219	CcSEcCtD
Pantoprazole—Headache—Docetaxel—pancreatic cancer	5.37e-05	0.000218	CcSEcCtD
Pantoprazole—Oedema—Doxorubicin—pancreatic cancer	5.35e-05	0.000218	CcSEcCtD
Pantoprazole—Anaphylactic shock—Doxorubicin—pancreatic cancer	5.35e-05	0.000218	CcSEcCtD
Pantoprazole—Infection—Doxorubicin—pancreatic cancer	5.31e-05	0.000216	CcSEcCtD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	5.29e-05	0.000799	CbGpPWpGaD
Pantoprazole—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	5.26e-05	0.000214	CcSEcCtD
Pantoprazole—Shock—Doxorubicin—pancreatic cancer	5.26e-05	0.000214	CcSEcCtD
Pantoprazole—Nervous system disorder—Doxorubicin—pancreatic cancer	5.24e-05	0.000213	CcSEcCtD
Pantoprazole—Thrombocytopenia—Doxorubicin—pancreatic cancer	5.23e-05	0.000213	CcSEcCtD
Pantoprazole—Insomnia—Epirubicin—pancreatic cancer	5.23e-05	0.000213	CcSEcCtD
Pantoprazole—Tachycardia—Doxorubicin—pancreatic cancer	5.22e-05	0.000212	CcSEcCtD
Pantoprazole—Skin disorder—Doxorubicin—pancreatic cancer	5.19e-05	0.000211	CcSEcCtD
Pantoprazole—Paraesthesia—Epirubicin—pancreatic cancer	5.19e-05	0.000211	CcSEcCtD
Pantoprazole—Hyperhidrosis—Doxorubicin—pancreatic cancer	5.17e-05	0.00021	CcSEcCtD
Pantoprazole—Dyspnoea—Epirubicin—pancreatic cancer	5.15e-05	0.00021	CcSEcCtD
Pantoprazole—Somnolence—Epirubicin—pancreatic cancer	5.14e-05	0.000209	CcSEcCtD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	5.12e-05	0.000772	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	5.12e-05	0.000772	CbGpPWpGaD
Pantoprazole—Anorexia—Doxorubicin—pancreatic cancer	5.1e-05	0.000207	CcSEcCtD
Pantoprazole—Nausea—Docetaxel—pancreatic cancer	5.09e-05	0.000207	CcSEcCtD
Pantoprazole—Dyspepsia—Epirubicin—pancreatic cancer	5.09e-05	0.000207	CcSEcCtD
Pantoprazole—Decreased appetite—Epirubicin—pancreatic cancer	5.02e-05	0.000204	CcSEcCtD
Pantoprazole—Hypotension—Doxorubicin—pancreatic cancer	5e-05	0.000203	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Epirubicin—pancreatic cancer	4.99e-05	0.000203	CcSEcCtD
Pantoprazole—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	4.99e-05	0.000753	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	4.98e-05	0.000752	CbGpPWpGaD
Pantoprazole—Fatigue—Epirubicin—pancreatic cancer	4.98e-05	0.000203	CcSEcCtD
Pantoprazole—Pain—Epirubicin—pancreatic cancer	4.94e-05	0.000201	CcSEcCtD
Pantoprazole—Constipation—Epirubicin—pancreatic cancer	4.94e-05	0.000201	CcSEcCtD
Pantoprazole—SLCO1B1—Metabolism—PRSS1—pancreatic cancer	4.94e-05	0.000745	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	4.92e-05	0.000743	CbGpPWpGaD
Pantoprazole—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	4.87e-05	0.000198	CcSEcCtD
Pantoprazole—Insomnia—Doxorubicin—pancreatic cancer	4.83e-05	0.000197	CcSEcCtD
Pantoprazole—Paraesthesia—Doxorubicin—pancreatic cancer	4.8e-05	0.000195	CcSEcCtD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	4.79e-05	0.000722	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	4.77e-05	0.00072	CbGpPWpGaD
Pantoprazole—Dyspnoea—Doxorubicin—pancreatic cancer	4.77e-05	0.000194	CcSEcCtD
Pantoprazole—Feeling abnormal—Epirubicin—pancreatic cancer	4.76e-05	0.000194	CcSEcCtD
Pantoprazole—Somnolence—Doxorubicin—pancreatic cancer	4.75e-05	0.000193	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.72e-05	0.000192	CcSEcCtD
Pantoprazole—Dyspepsia—Doxorubicin—pancreatic cancer	4.71e-05	0.000191	CcSEcCtD
Pantoprazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	4.68e-05	0.000706	CbGpPWpGaD
Pantoprazole—Decreased appetite—Doxorubicin—pancreatic cancer	4.65e-05	0.000189	CcSEcCtD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	4.64e-05	0.0007	CbGpPWpGaD
Pantoprazole—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	4.62e-05	0.000188	CcSEcCtD
Pantoprazole—Fatigue—Doxorubicin—pancreatic cancer	4.61e-05	0.000188	CcSEcCtD
Pantoprazole—Urticaria—Epirubicin—pancreatic cancer	4.59e-05	0.000187	CcSEcCtD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	4.59e-05	0.000692	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	4.58e-05	0.00069	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PRSS1—pancreatic cancer	4.57e-05	0.00069	CbGpPWpGaD
Pantoprazole—Pain—Doxorubicin—pancreatic cancer	4.57e-05	0.000186	CcSEcCtD
Pantoprazole—Constipation—Doxorubicin—pancreatic cancer	4.57e-05	0.000186	CcSEcCtD
Pantoprazole—Body temperature increased—Epirubicin—pancreatic cancer	4.57e-05	0.000186	CcSEcCtD
Pantoprazole—Abdominal pain—Epirubicin—pancreatic cancer	4.57e-05	0.000186	CcSEcCtD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	4.55e-05	0.000687	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	4.49e-05	0.000677	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	4.49e-05	0.000677	CbGpPWpGaD
Pantoprazole—Feeling abnormal—Doxorubicin—pancreatic cancer	4.41e-05	0.000179	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Doxorubicin—pancreatic cancer	4.37e-05	0.000178	CcSEcCtD
Pantoprazole—SLCO1B1—Metabolism—ARG2—pancreatic cancer	4.28e-05	0.000646	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	4.27e-05	0.000645	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	4.27e-05	0.000645	CbGpPWpGaD
Pantoprazole—Hypersensitivity—Epirubicin—pancreatic cancer	4.26e-05	0.000173	CcSEcCtD
Pantoprazole—Urticaria—Doxorubicin—pancreatic cancer	4.25e-05	0.000173	CcSEcCtD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	4.24e-05	0.000639	CbGpPWpGaD
Pantoprazole—Abdominal pain—Doxorubicin—pancreatic cancer	4.23e-05	0.000172	CcSEcCtD
Pantoprazole—Body temperature increased—Doxorubicin—pancreatic cancer	4.23e-05	0.000172	CcSEcCtD
Pantoprazole—Asthenia—Epirubicin—pancreatic cancer	4.15e-05	0.000169	CcSEcCtD
Pantoprazole—Pruritus—Epirubicin—pancreatic cancer	4.09e-05	0.000166	CcSEcCtD
Pantoprazole—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	4.05e-05	0.000611	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—ARG2—pancreatic cancer	3.97e-05	0.000598	CbGpPWpGaD
Pantoprazole—Diarrhoea—Epirubicin—pancreatic cancer	3.95e-05	0.000161	CcSEcCtD
Pantoprazole—Hypersensitivity—Doxorubicin—pancreatic cancer	3.94e-05	0.00016	CcSEcCtD
Pantoprazole—Asthenia—Doxorubicin—pancreatic cancer	3.84e-05	0.000156	CcSEcCtD
Pantoprazole—Dizziness—Epirubicin—pancreatic cancer	3.82e-05	0.000155	CcSEcCtD
Pantoprazole—Pruritus—Doxorubicin—pancreatic cancer	3.78e-05	0.000154	CcSEcCtD
Pantoprazole—SLCO1B1—Metabolism—TYMP—pancreatic cancer	3.74e-05	0.000565	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	3.72e-05	0.000561	CbGpPWpGaD
Pantoprazole—Vomiting—Epirubicin—pancreatic cancer	3.67e-05	0.000149	CcSEcCtD
Pantoprazole—Diarrhoea—Doxorubicin—pancreatic cancer	3.66e-05	0.000149	CcSEcCtD
Pantoprazole—Rash—Epirubicin—pancreatic cancer	3.64e-05	0.000148	CcSEcCtD
Pantoprazole—Dermatitis—Epirubicin—pancreatic cancer	3.64e-05	0.000148	CcSEcCtD
Pantoprazole—Headache—Epirubicin—pancreatic cancer	3.62e-05	0.000147	CcSEcCtD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	3.6e-05	0.000543	CbGpPWpGaD
Pantoprazole—Dizziness—Doxorubicin—pancreatic cancer	3.53e-05	0.000144	CcSEcCtD
Pantoprazole—ABCB1—Allograft Rejection—TNF—pancreatic cancer	3.47e-05	0.000524	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—TYMP—pancreatic cancer	3.47e-05	0.000523	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	3.45e-05	0.000521	CbGpPWpGaD
Pantoprazole—Nausea—Epirubicin—pancreatic cancer	3.43e-05	0.00014	CcSEcCtD
Pantoprazole—Vomiting—Doxorubicin—pancreatic cancer	3.4e-05	0.000138	CcSEcCtD
Pantoprazole—Rash—Doxorubicin—pancreatic cancer	3.37e-05	0.000137	CcSEcCtD
Pantoprazole—Dermatitis—Doxorubicin—pancreatic cancer	3.37e-05	0.000137	CcSEcCtD
Pantoprazole—Headache—Doxorubicin—pancreatic cancer	3.35e-05	0.000136	CcSEcCtD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	3.3e-05	0.000499	CbGpPWpGaD
Pantoprazole—Nausea—Doxorubicin—pancreatic cancer	3.18e-05	0.000129	CcSEcCtD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.09e-05	0.000466	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GLP1R—pancreatic cancer	3.02e-05	0.000455	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	3.01e-05	0.000454	CbGpPWpGaD
Pantoprazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	2.98e-05	0.00045	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—DPYD—pancreatic cancer	2.97e-05	0.000448	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—SLC2A2—pancreatic cancer	2.82e-05	0.000425	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GLP1R—pancreatic cancer	2.79e-05	0.000422	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.79e-05	0.000421	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—DPYD—pancreatic cancer	2.75e-05	0.000415	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.69e-05	0.000406	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—SLC2A2—pancreatic cancer	2.61e-05	0.000394	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	2.54e-05	0.000383	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PRSS1—pancreatic cancer	2.53e-05	0.000382	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PRSS1—pancreatic cancer	2.47e-05	0.000373	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.45e-05	0.00037	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	2.36e-05	0.000355	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PRSS1—pancreatic cancer	2.31e-05	0.000349	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	2.29e-05	0.000346	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	2.27e-05	0.000343	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	2.21e-05	0.000334	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ARG2—pancreatic cancer	2.2e-05	0.000331	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CD44—pancreatic cancer	2.18e-05	0.000329	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ARG2—pancreatic cancer	2.14e-05	0.000324	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.14e-05	0.000322	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.12e-05	0.000319	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GCG—pancreatic cancer	2.09e-05	0.000316	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.05e-05	0.00031	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CD44—pancreatic cancer	2.02e-05	0.000305	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ARG2—pancreatic cancer	2e-05	0.000302	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2e-05	0.000302	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PRSS1—pancreatic cancer	1.97e-05	0.000298	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—STK11—pancreatic cancer	1.97e-05	0.000297	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GCG—pancreatic cancer	1.94e-05	0.000292	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—TYMP—pancreatic cancer	1.92e-05	0.00029	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—TYMP—pancreatic cancer	1.87e-05	0.000283	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.85e-05	0.000279	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.84e-05	0.000278	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.83e-05	0.000277	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—STK11—pancreatic cancer	1.82e-05	0.000275	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.8e-05	0.000271	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—TYMP—pancreatic cancer	1.75e-05	0.000264	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.71e-05	0.000258	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ARG2—pancreatic cancer	1.71e-05	0.000258	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.7e-05	0.000256	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—TYMS—pancreatic cancer	1.69e-05	0.000255	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.58e-05	0.000239	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—TYMS—pancreatic cancer	1.57e-05	0.000236	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.56e-05	0.000236	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GLP1R—pancreatic cancer	1.55e-05	0.000234	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.52e-05	0.00023	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—DPYD—pancreatic cancer	1.52e-05	0.00023	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.51e-05	0.000228	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.51e-05	0.000228	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—TYMP—pancreatic cancer	1.5e-05	0.000226	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—DPYD—pancreatic cancer	1.49e-05	0.000224	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	1.45e-05	0.000218	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.44e-05	0.000218	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.43e-05	0.000216	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GLP1R—pancreatic cancer	1.41e-05	0.000213	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.41e-05	0.000213	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—DPYD—pancreatic cancer	1.39e-05	0.000209	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.38e-05	0.000208	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—APOE—pancreatic cancer	1.38e-05	0.000208	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.32e-05	0.000199	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	1.32e-05	0.000199	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.3e-05	0.000197	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.3e-05	0.000196	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.28e-05	0.000192	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—APOE—pancreatic cancer	1.27e-05	0.000192	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.26e-05	0.00019	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.26e-05	0.00019	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CG—pancreatic cancer	1.24e-05	0.000187	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.23e-05	0.000186	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GLP1R—pancreatic cancer	1.21e-05	0.000182	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PPARG—pancreatic cancer	1.2e-05	0.000181	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—DPYD—pancreatic cancer	1.19e-05	0.000179	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.15e-05	0.000174	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CG—pancreatic cancer	1.15e-05	0.000173	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.15e-05	0.000173	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	1.13e-05	0.00017	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CD44—pancreatic cancer	1.12e-05	0.000169	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.11e-05	0.000168	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PPARG—pancreatic cancer	1.11e-05	0.000167	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.1e-05	0.000165	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CD44—pancreatic cancer	1.09e-05	0.000165	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CD—pancreatic cancer	1.09e-05	0.000165	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.09e-05	0.000164	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.08e-05	0.000162	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GCG—pancreatic cancer	1.07e-05	0.000162	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GCG—pancreatic cancer	1.05e-05	0.000158	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CD44—pancreatic cancer	1.02e-05	0.000154	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CD—pancreatic cancer	1.01e-05	0.000152	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—STK11—pancreatic cancer	1.01e-05	0.000152	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	9.99e-06	0.000151	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	9.9e-06	0.000149	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—STK11—pancreatic cancer	9.85e-06	0.000149	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.8e-06	0.000148	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GCG—pancreatic cancer	9.78e-06	0.000148	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CB—pancreatic cancer	9.51e-06	0.000144	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	9.47e-06	0.000143	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PTGS2—pancreatic cancer	9.43e-06	0.000142	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GLP1R—pancreatic cancer	9.31e-06	0.00014	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—STK11—pancreatic cancer	9.2e-06	0.000139	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—DPYD—pancreatic cancer	9.16e-06	0.000138	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CB—pancreatic cancer	8.81e-06	0.000133	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PTGS2—pancreatic cancer	8.73e-06	0.000132	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CD44—pancreatic cancer	8.72e-06	0.000132	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	8.69e-06	0.000131	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—TYMS—pancreatic cancer	8.68e-06	0.000131	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	8.63e-06	0.00013	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.54e-06	0.000129	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—TYMS—pancreatic cancer	8.47e-06	0.000128	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.46e-06	0.000128	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GCG—pancreatic cancer	8.36e-06	0.000126	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PTEN—pancreatic cancer	8.22e-06	0.000124	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—TYMS—pancreatic cancer	7.91e-06	0.000119	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—STK11—pancreatic cancer	7.86e-06	0.000119	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PTEN—pancreatic cancer	7.61e-06	0.000115	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.38e-06	0.000111	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—APOE—pancreatic cancer	7.06e-06	0.000106	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—APOE—pancreatic cancer	6.89e-06	0.000104	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—TYMS—pancreatic cancer	6.76e-06	0.000102	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CD44—pancreatic cancer	6.73e-06	0.000102	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.68e-06	0.000101	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GCG—pancreatic cancer	6.45e-06	9.73e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—APOE—pancreatic cancer	6.43e-06	9.71e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	6.37e-06	9.61e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CG—pancreatic cancer	6.22e-06	9.38e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PPARG—pancreatic cancer	6.15e-06	9.27e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.09e-06	9.19e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—STK11—pancreatic cancer	6.07e-06	9.15e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PPARG—pancreatic cancer	6e-06	9.05e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	5.81e-06	8.76e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CA—pancreatic cancer	5.8e-06	8.75e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PPARG—pancreatic cancer	5.6e-06	8.46e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	5.6e-06	8.45e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—APOE—pancreatic cancer	5.5e-06	8.3e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CD—pancreatic cancer	5.46e-06	8.24e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CA—pancreatic cancer	5.37e-06	8.1e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—TYMS—pancreatic cancer	5.22e-06	7.87e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.21e-06	7.85e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	5.11e-06	7.7e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	4.96e-06	7.49e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	4.88e-06	7.36e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PTGS2—pancreatic cancer	4.84e-06	7.3e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PPARG—pancreatic cancer	4.79e-06	7.23e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CB—pancreatic cancer	4.76e-06	7.19e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—AKT1—pancreatic cancer	4.74e-06	7.15e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PTGS2—pancreatic cancer	4.72e-06	7.12e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	4.45e-06	6.71e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PTGS2—pancreatic cancer	4.41e-06	6.65e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—AKT1—pancreatic cancer	4.39e-06	6.62e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	4.36e-06	6.58e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—APOE—pancreatic cancer	4.24e-06	6.4e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PTEN—pancreatic cancer	4.22e-06	6.36e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PTEN—pancreatic cancer	4.12e-06	6.21e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PTEN—pancreatic cancer	3.85e-06	5.8e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	3.83e-06	5.78e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	3.8e-06	5.74e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PTGS2—pancreatic cancer	3.77e-06	5.68e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PPARG—pancreatic cancer	3.7e-06	5.58e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.37e-06	5.08e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PTEN—pancreatic cancer	3.29e-06	4.96e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	2.98e-06	4.49e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.93e-06	4.43e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.91e-06	4.39e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CA—pancreatic cancer	2.9e-06	4.38e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	2.71e-06	4.09e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.54e-06	3.83e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—AKT1—pancreatic cancer	2.43e-06	3.67e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—AKT1—pancreatic cancer	2.37e-06	3.58e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	2.32e-06	3.5e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—AKT1—pancreatic cancer	2.22e-06	3.34e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.89e-06	2.86e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.79e-06	2.7e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.46e-06	2.2e-05	CbGpPWpGaD
